← THE WIRE
1D EOD · SEP 25 CLOSE
● Regulation · CryptoYahoo Finance · AI-written from Yahoo Finance reporting · checked automatically, not by a personWho answers for this

Coinbase files for SEC approval to offer equity perpetuals

Coinbase has filed with the SEC for approval to offer equity perpetuals, adding a proposed derivatives product to its crypto-market platform. The filing creates a regulatory catalyst around product expansion, but the available disclosures do not establish approval timing, economics or a clear near-term earnings impact.

Keep this report. See new evidence in Following.
The storyAI-written · 1 min read

Coinbase submitted an application to the U.S. Securities and Exchange Commission seeking approval to offer equity perpetuals, according to Yahoo Finance reporting published September 3, 2026. The proposed product would extend Coinbase’s platform beyond its existing offerings into a derivatives format tied to equities.

The filing comes as Coinbase’s latest available financial data show FY 2025 revenue of $7.2B, up 9.4% year over year, with diluted EPS of $4.45 and net margin of 18.1%. Those figures establish the company’s current operating base. No prior approval decision or launch date is identified in the supplied reporting.

For Coinbase, the potential mechanism is a new transaction and derivatives-related revenue line if the SEC approves the application and customers use the contracts. The SEC is the key regulatory counterparty because its approval is the immediate gate to the proposed offering. Equity issuers and market participants could also be affected by the product’s eventual structure.

The main uncertainty is regulatory, not financial guidance. The source establishes that Coinbase filed for approval.

The next decisive disclosure would be an SEC response or a subsequent Coinbase announcement describing the product, its launch conditions and the assets covered. Investors would also need a later company filing or earnings update to determine whether equity perpetuals generate material revenue relative to the reported $7.2B base. Until those details appear, the filing is a product-expansion catalyst with uncertain timing rather than a quantified earnings event.

The read · Sep 3

The SEC filing adds a potential derivatives growth lane for COIN, but the lack of approval, launch timing and revenue detail keeps the read balanced.

The filing’s value lies in a possible new transaction-revenue channel, but the evidence does not yet show approval, launch timing or economics. Coinbase’s $7.2B FY 2025 revenue base and 18.1% net margin provide scale for comparison, while the absence of product-specific figures prevents a directional earnings read.

What could change this view

The trade loses its expansion thesis if the SEC rejects or materially restricts the product.

CoverageSource: Yahoo Finance · Published here THU, SEP 3 · 5:30 PM ET · the only report in this recordHow this is decided →

Named in the readCOIN -2.1%1D EOD · SEP 25
The Securities and Exchange Commission’s headquarters, Washington — file photoFile photo · The Securities and Exchange Commission’s headquarters, Washington · Oct 2008 · David (Flickr: dbking) · CC BY 2.0 · Source & license
The chart · COINTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
Story timeline0 later reports

Earlier context and later coverage are dated relative to this report. Automatically linked reports may cover a broader event.

You are reading this report

No later reports linked yet.

Follow this story to find new evidence in your Following desk.

Since this story · named here, equal weight · 1D EOD+5.7%
SEP 4 · first close after publicationSEP 25

Price context does not establish that the story caused the move.

▲ The case it holds

An SEC approval could give Coinbase another derivatives-based revenue channel on top of FY 2025 revenue of $7.2B, with the filing serving as an early product-expansion signal.

▼ The case it breaks

The bear case is that the filing produces no near-term financial benefit because approval, launch timing, demand, costs and product economics are all undisclosed.

Receipts
Research, not advice.

Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →

SharePost on X
READER EVIDENCEOpens with the recordFollow the story to be told when it moves.